Tax Management India. Com
Law and Practice  :  Digital eBook
Research is most exciting & rewarding
  TMI - Tax Management India. Com
Follow us:
  Facebook   Twitter   Linkedin   Telegram
Income Tax - Highlights / Catch Notes

Home Highlights January 2022 Year 2022 This

Disallowance of expenses u/s 37(1) - Pharmaceutical Companies - ...


Pharmaceutical Expenses: Beneficial Circulars Applied Retrospectively, C.B.D.T. Circular No.5 of 2012 Not Retroactive for AY 2010-11.

January 19, 2022

Case Laws     Income Tax     HC

Disallowance of expenses u/s 37(1) - Pharmaceutical Companies - proportionate expenditure incurred on medical practitioners - It has been held therein that while beneficial circulars have to be applied retrospectively, oppressive circulars would have prospective application. In view of this it is clear that C.B.D.T. Circular No.5 of 2012 imposes a new kind of imparity and thus the view taken in the aforesaid decisions by the Tribunal is in consonance with the law laid down by the Hon’ble Supreme Court. It is thus clear that the said Circular could not have been applied retrospectively and especially to Assessment Year 2010-11 in the present case. - HC

View Source

 


 

You may also like:

  1. CENVAT Credit - Export of services or exempted services during the relevant period - Circular dated 9-5-2008 - beneficial circular has to be applied retrospectively...

  2. Refund claim of Additional duty of Customs - Refund claim of SAD - Limitation - beneficial circular to be applied retrospectively while oppressive circular applicable...

  3. Disallowance on account of gift expenses - expenses incurred in providing freebees to Medical Practitioner by Pharmaceutical and allied Heath Sector Industry - Circular...

  4. The High Court allowed the petition and quashed the impugned order rejecting the petitioner's refund application for unutilized input tax credit. The court held that the...

  5. SEBI Circular applicability - We have already held that the SEBI Circular cannot be applied to defaults committed prior to 13th October, 2020. This being so, the...

  6. Interpretation of Section 16(5) of CGST Act regarding input tax credit. Circular issued by Government of India No. 237/31/2024-GST dated 15th October 2024. Petitioner...

  7. Grant of Moratorium due to COVID-19 pandemic situation - Restraint on respondent from recovering loan repayment instalments/EMI due - RBI Circular dated 27.03.2020 -...

  8. The Securities and Exchange Board of India (SEBI) issued a Master Circular consolidating all relevant circulars and communications pertaining to depositories up to...

  9. The Master Circular issued by SEBI on May 30, 2024, applies to Foreign Portfolio Investors (FPIs), Designated Depository Participants (DDPs), and Eligible Foreign...

  10. Constitutional Validity of Circular - The court examined whether the Circular introduced new legal standards beyond the scope of the IBBI's authority and whether it...

  11. Classification of goods - import of PU coated leather cloths - test report of CLRI mentions the goods as ‘flock fabric’ - Circular dated 06.10.1998 - The said circular...

  12. The Master Circular for Commodity Derivatives Segment issued by SEBI consolidates circulars up to March 31, 2023. It replaces previous circulars and applies to stock...

  13. Validity of Policy Circular - SFIS Scheme - Since the said Circular does not take away the benefits that have accrued on the basis of the SFI Scheme prior to the...

  14. Various issues related to allowability of expenses, deductions, transfer pricing adjustments, and other income tax matters for a pharmaceutical company. Key points are:...

  15. The Reserve Bank of India (RBI) issued Circular No. 05 on May 08, 2024, regarding Margin for Derivative Contracts. This circular supersedes the previous Circular No. 10...

 

Quick Updates:Latest Updates